- Docetaxel in the treatment of breast cancer in the Department of Radiotherapy and Oncology, Faculty Hospital Motol2000 | Publication without faculty affiliation
- New indication of docetaxel2005 | First Faculty of Medicine
- Docetaxel labeled with iodine 131 radionuclide - a possible new anticancer drug? (The pilot study)2006 | Faculty of Medicine in Hradec Králové
- Docetaxel labeled with radionuclide shows high efficiency against cervical cancer cell lines in vitro2007 | Faculty of Medicine in Hradec Králové
- Docetaxel-Cabazitaxel-Enzalutamide Versus Docetaxel-Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer2017 | First Faculty of Medicine
- Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer2007 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Komentář k metaanalýze studií nintedanib + docetaxel2018 | Second Faculty of Medicine
- A role of Docetaxel (Taxotere) in NSCLC treatmentPublication without faculty affiliation
- Kastračně rezistentní karcinom prostaty - nové sekvence léčby v klinické praxi: zařazení nových inhibitorů androgenní osy v léčbě CRPC před docetaxel: proPublication without faculty affiliation
- Options of Chemotherapy in the Treatment of Prostate Cancer2017 | First Faculty of Medicine
- Research Report University Hospital for clinical assessment Go27983Publication without faculty affiliation
- Metastatic prostate cancer - changes in treatment strategy2019 | First Faculty of Medicine
- New approaches in palliative systemic therapy of anal squamous cell carcinoma2022 | First Faculty of Medicine
- New hormonal agents in castration-resistant prostate cancer2013 | First Faculty of Medicine
- Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323).2010 | First Faculty of Medicine
- Shifting paradigms in prostate cancer; docetaxel plus low-dose prednisone - finally an effective chemotherapy2005 | First Faculty of Medicine
- Chemotherapy for hormonally sensitive prostate carcinoma2017 | First Faculty of Medicine
- Trends in the treatment of metastatic castration-sensitive prostate cancer2023 | First Faculty of Medicine, Faculty of Physical Education and Sport
- New treatment options in hormone-sensitive prostate cancer +12019 | First Faculty of Medicine
- Možnosti léčby karcinomu prostaty po selhání docetaxelu2015 | First Faculty of Medicine
- Antitumour activity of a combined treatment with PMEDAP and docetaxel in the Prague inbred Sprague-Dawley/cub rat strain bearing T-cell lymphoma2001 | Third Faculty of Medicine
- Cabazitaxel for the treatment of metastatic castration-resistant prostate cancer2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Komentář ke studii: Cabazitaxel a abirateron acetát po selhání docetaxelu v léčbě pacientů s metastazujícím kastračně rezistentním karcinomem prostaty2015 | Third Faculty of Medicine
- Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?2005 | Publication without faculty affiliation
- Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?2005 | First Faculty of Medicine
- Docetaxel labeled with iodine 131 radionuclide - a possible new anticancer drug?2006 | Faculty of Pharmacy in Hradec Králové
- Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy2016 | Second Faculty of Medicine
- Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer2007 | Publication without faculty affiliation
- Docetaxel labeled with radionuclide shows high efficiency against cervical cancer cell lines in vitro2007 | Publication without faculty affiliation